The company will study its vaccine in children ages six months through 11 in the United States and Canada.
Published: March 16, 2021 at 10:04PM
from NYT Health https://ift.tt/38MJyxw
The company will study its vaccine in children ages six months through 11 in the United States and Canada.
Published: March 16, 2021 at 10:04PM
from NYT Health https://ift.tt/38MJyxw